BLT 0.00% 2.6¢ benitec biopharma limited

Silence & Replace Sub-licence

  1. 536 Posts.
    lightbulb Created with Sketch. 1
    Hoyland or anyone else- what are your thoughts about Benitec doing a potential sub-license agreement with Regenxbio to sell our silence & replace vector technology to their existing customer base?

    Below is a Barron's article quote regarding Regenxbio partnerships & royalties...

    "Amusa, the Chardan analyst, favors Regenxbio, calling it “the best way to broadly play the emergence of vector-based gene therapy.” The company, based in Rockville, Md., is licensing viral vectors to about 10 partners, including AveXis and Audentes, and will get royalties estimated at about 10% if those treatments are commercialized."

    Regenxbio could be an efficient route for Benitec to sell it's silence & replace expertise tech to multiple partners quickly because of Regenxbio established partnerships with many biotech companies..
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.